• F18-FDG-PET for recurrent differentiated thyroid cancer: a systematic meta-analysis 

      Haslerud, Torjan Magne; Brauckhoff, Katrin; Reisæter, Lars Anders Rokne; Lein, Regina Küfner; Heinecke, A.; Varhaug, Jan Erik; Biermann, Martin (Peer reviewed; Journal article, 2015-07-09)
      Background Positron emission tomography (PET) with fluor-18-deoxy-glucose (FDG) is widely used for diagnosing recurrent or metastatic disease in patients with differentiated thyroid cancer (DTC). Purpose To assess the ...
    • Metabolic risk score and cancer risk: pooled analysis of seven cohorts 

      Stocks, Tanja; Bjørge, Tone; Ulmer, Hanno; Manjer, Jonas; Häggström, Christel; Nagel, Gabriele; Engeland, Anders; Johansen, Dorthe; Hallmans, Göran; Selmer, Randi; Concin, Hans; Tretli, Steinar; Jonsson, Håkan; Stattin, Pär (Peer reviewed; Journal article, 2015)
      Background: There are few data on the joint influence of metabolic factors on risk of separate cancers. Methods: We analysed data on body mass index, blood pressure and plasma levels of glucose, total cholesterol and ...
    • Post-PET ultrasound improves specificity of 18F-FDG-PET for recurrent differentiated thyroid cancer while maintaining sensitivity 

      Biermann, Martin; Kråkenes, Jostein; Brauckhoff, Katrin; Haugland, Hans Kristian; Akslen, Lars A.; Heinecke, A.; Varhaug, Jan Erik; Brauckhoff, Michael (Peer reviewed; Journal article, 2015-03-13)
      Background: Positron emission tomography (PET) using fluor-18-deoxyglucose (18F-FDG) with or without computed tomography (CT) is generally accepted as the most sensitive imaging modality for diagnosing recurrent differentiated ...